Combating Antibiotic Resistance: A Call for Collaboration

Methicillin resistant Staphylococcus aureus (MRSA) (cdc.gov)

Here is a nice op-ed article by Carl Nathan that appeared in Sunday's New York Times. Nathan discusses the problem of antibiotic resistance and the challenges to new drug development, including bacteria that rapidly develop resistance to new antibiotics and poor economic incentives for industry to create new drugs.

Nathan highlights novel collaborations between industry, government and the non-profit sector designed to expedite new drug discovery. The Infectious Diseases Society of America has great information on the problem of antibiotic resistance (and potential solutions) that can be found here.